1. Home
  2. BDRX vs SLE Comparison

BDRX vs SLE Comparison

Compare BDRX & SLE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • BDRX
  • SLE
  • Stock Information
  • Founded
  • BDRX 2000
  • SLE 2014
  • Country
  • BDRX United Kingdom
  • SLE United States
  • Employees
  • BDRX N/A
  • SLE N/A
  • Industry
  • BDRX Biotechnology: Pharmaceutical Preparations
  • SLE Services-Misc. Amusement & Recreation
  • Sector
  • BDRX Health Care
  • SLE Consumer Discretionary
  • Exchange
  • BDRX Nasdaq
  • SLE Nasdaq
  • Market Cap
  • BDRX 3.8M
  • SLE 3.6M
  • IPO Year
  • BDRX N/A
  • SLE 2019
  • Fundamental
  • Price
  • BDRX $6.07
  • SLE $2.99
  • Analyst Decision
  • BDRX
  • SLE Strong Buy
  • Analyst Count
  • BDRX 0
  • SLE 2
  • Target Price
  • BDRX N/A
  • SLE $100.00
  • AVG Volume (30 Days)
  • BDRX 49.7K
  • SLE 90.9K
  • Earning Date
  • BDRX 09-29-2025
  • SLE 08-14-2025
  • Dividend Yield
  • BDRX N/A
  • SLE N/A
  • EPS Growth
  • BDRX N/A
  • SLE N/A
  • EPS
  • BDRX N/A
  • SLE N/A
  • Revenue
  • BDRX N/A
  • SLE $13,576,000.00
  • Revenue This Year
  • BDRX N/A
  • SLE N/A
  • Revenue Next Year
  • BDRX N/A
  • SLE $30.36
  • P/E Ratio
  • BDRX N/A
  • SLE N/A
  • Revenue Growth
  • BDRX N/A
  • SLE N/A
  • 52 Week Low
  • BDRX $5.00
  • SLE $2.75
  • 52 Week High
  • BDRX $108.90
  • SLE $46.80
  • Technical
  • Relative Strength Index (RSI)
  • BDRX 45.24
  • SLE 38.33
  • Support Level
  • BDRX $5.00
  • SLE $2.75
  • Resistance Level
  • BDRX $6.32
  • SLE $3.24
  • Average True Range (ATR)
  • BDRX 0.52
  • SLE 0.25
  • MACD
  • BDRX 0.12
  • SLE 0.03
  • Stochastic Oscillator
  • BDRX 54.27
  • SLE 27.65

About BDRX Biodexa Pharmaceuticals plc

Biodexa Pharmaceuticals PLC is a clinical-stage biopharmaceutical company focused on developing a pipeline of products to treat diseases that have unmet medical needs. These include familial adenomatous polyposis (FAP), non-muscle invasive bladder cancer (NMIBC), type 1 diabetes (T1D), and rare or orphan brain cancers.

About SLE Super League Enterprise Inc.

Super League Enterprise Inc is the rocket ship to the metaverse. It is a creator and publisher of content experiences and media solutions across the globe's immersive platforms. Its solutions provide incomparable access to massive audiences that gather in immersive digital spaces to socialize, play, explore, collaborate, shop, learn, and create. The company offers a complete range of development, distribution, monetization, and optimization capabilities designed to engage users through dynamic, energized programs. It generates revenue from advertising, including immersive game world and experience publishing and in-game media products, direct-to-consumer offers, including in-game items, e-commerce, game passes and ticketing and digital collectibles, and content and technology.

Share on Social Networks: